StreetInsider.com News Articles

Form 8-K Medline Inc. For: Oct 13

Thu, 15 Oct 2026 16:19:00 -0400

si-local-file:///var/storage/secattach/20261015/27193637.html

Medline plans 800,000-sq-ft distribution center in Michigan

Thu, 15 Oct 2026 14:23:08 -0400

Medline (Nasdaq: MDLN) has announced plans to open a new distribution center in Van Buren Township, Mich., a suburb of Detroit, according to a company press release.

The facility, totaling approximately 800,000 square feet, is being developed by Ashley Capital at its Crossroads Distribution Center North industrial park. The site is expected to begin serving customers in late 2028.

Billy Abrams, executive vice president of supply chain solutions at Medline, said the facility is intended to add capacity and flexibility in the Midwest market. "The new facility allows us to add capacity and flexibility in a key Midwest market while giving our

Medline to build Midwestern network with new 800,000-square-foot facility in Van Buren Township, Mich.

Thu, 15 Oct 2026 14:17:00 -0400

State-of-the-art facility planned to reinforce Medline's supply chain resilience in Michigan

NORTHFIELD, Ill., Oct. 15, 2026 /PRNewswire/ -- Medline (Nasdaq: MDLN), the largest provider of medical-surgical products and supply chain solutions serving all points of care, has announced plans to open a new distribution center in Van Buren Township, Mich., a suburb of Detroit.

Medline to build Midwestern network with new 800,000-square-foot facility in Van Buren Township, Mich.

Thu, 15 Oct 2026 14:17:00 -0400

State-of-the-art facility planned to reinforce Medline's supply chain resilience in Michigan

Form 4 Medline Inc. For: Oct 08 Filed by: GIC Special Investments Pte Ltd

Tue, 13 Oct 2026 09:26:00 -0400

si-local-file:///var/storage/secattach/20261013/27178807.html

Medline updates TrackPoint inventory tool for post-acute care

Mon, 12 Oct 2026 16:26:48 -0400

Medline (Nasdaq: MDLN) announced the launch of an enhanced version of its TrackPoint™ inventory management platform, designed for long-term care and inpatient hospice providers, according to a company press release.

The updated platform adds integration with PointClickCare® for real-time patient data syncing and includes capabilities such as barcode scanning, multi-location inventory tracking, and standardized supply workflows. The tool also connects to Medline.com to streamline purchasing and reduce duplicate data entry.

TrackPoint is intended to help facilities track Medline supplies, capture patient-level usage data, and monitor inventory across multiple locations.

"We know that our customers, especially in post-acute care, often don't have access to

Medline updates TrackPoint inventory tool for post-acute care

Mon, 12 Oct 2026 16:26:48 -0400

TrackPoint is intended to help facilities track Medline supplies, capture patient-level usage data, and monitor inventory across multiple locations.

"We know that our customers, especially in post-acute care, often don't have access to

Medline launches enhanced TrackPoint™ to simplify inventory management for post-acute care

Mon, 12 Oct 2026 16:25:00 -0400

Combines real-time inventory tracking with PointClickCare® integration to reduce manual work and improve supply visibility

NORTHFIELD, Ill., Oct. 12, 2026 /PRNewswire/ -- Medline (Nasdaq: MDLN) today announced the launch of an enhanced version of TrackPoint™, its online inventory management and patient item usage solution designed to help long-term care and inpatient hospice providers more easily track supplies from

Medline launches enhanced TrackPoint™ to simplify inventory management for post-acute care

Mon, 12 Oct 2026 16:25:00 -0400

Combines real-time inventory tracking with PointClickCare® integration to reduce manual work and improve supply visibility

Medline Inc (MDLN) PT Lowered to $43 at Barclays

Fri, 09 Oct 2026 05:00:08 -0400

Barclays analyst Glen Santangelo lowered the price target on Medline Inc (NASDAQ: MDLN) to $43.00 (from $45.00) while maintaining a Overweight rating.

Form 4 Medline Inc. For: Oct 02 Filed by: GIC Private Ltd

Tue, 06 Oct 2026 21:48:00 -0400

si-local-file:///var/storage/secattach/20261006/27156719.html

Medline to report third quarter 2026 results on November 4, 2026

Tue, 06 Oct 2026 09:00:00 -0400

NORTHFIELD, Ill., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that it plans to report third quarter 2026 financial results on Wednesday, November 4, 2026. A press release and supplemental materials will be issued before the market opens. The company will host a webcast and conference call at 9:30am ET/ 8:30am CT to discuss the financial results.

Information about Medline’s financial results, including a link to the live webcast, will be available on the Events page of Medline’s Investor Relations website at ir.medline.com. A replay of the

Medline to report third quarter 2026 results on November 4, 2026

Tue, 06 Oct 2026 09:00:00 -0400

William Blair Reiterates Outperform Rating on Medline Inc (MDLN)

Wed, 23 Sep 2026 06:03:38 -0400

William Blair analyst Brandon Vazquez reiterated an Outperform rating and {REMOVEPT} price target on Medline Inc (NASDAQ: MDLN)

The analyst comments "Bottom line: We are updating our Medline estimates to better reflect management’s commentary at recent conferences, our discussion with management, and the impact of rising commodity prices on the company’s P&L statement. Our revenue estimates are unchanged, with the only changes coming from margins as we better reflect commodity prices and Medline’s commentary that it will likely absorb inflation related costs until 2027. In 2026, our updated EBITDA estimates put us closer to the lower end of the guidance range,

Medline stock climbs from 52-week low levels

Tue, 22 Sep 2026 10:13:32 -0400

Medline Inc. shares rose nearly 5.0% during morning trading on Tuesday, rebounding from levels close to the stock's 52-week low of $31.49. The company did not release any announcements on the day.

Around 20 Wall Street analysts cover the stock, with most holding Buy-equivalent ratings. The average 12-month price target stands well above current trading levels.

The stock has traded at levels below analyst consensus targets for an extended period.

INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Medline Inc. to Contact Law Firm

Tue, 15 Sep 2026 15:58:00 -0400

Medline Inc. (NASDAQ: MDLN) shareholders should email fletcher@fmoorelaw.com

NEW YORK, Sept. 15, 2026 (GLOBE NEWSWIRE) --

What is the Investigation About?

On June 2, 2026, the Federal Drug Administration (“FDA”) published a warning letter dated May 28, 2026 addressed to Medline summarizing “significant violations of Current Good Manufacturing Practice regulations for finished pharmaceuticals[.]” The FDA further states that Medline “failed to thoroughly investigate any unexplained discrepancy or failure of a batch or any of its components to meet any of its specifications.”

Following this news, the price of Medline

INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Medline Inc. to Contact Law Firm

Tue, 15 Sep 2026 15:58:00 -0400

Medline Inc. (NASDAQ: MDLN) shareholders should email fletcher@fmoorelaw.com

NEW YORK, Sept. 15, 2026 (GLOBE NEWSWIRE) --

What is the Investigation About?

Following this news, the price of Medline

Medline announces participation in the Morgan Stanley 24th Annual Global Healthcare Conference

Thu, 03 Sep 2026 08:30:00 -0400

NORTHFIELD, Ill., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that Jim Boyle, chief executive officer, and Mike Drazin, chief financial officer, are scheduled to present at the Morgan Stanley 24th Annual Global Healthcare Conference in New York, NY, on Tuesday, September 15, 2026, at 12:20pm ET.

A webcast of the presentation will be available on the Events page of Medline’s Investor Relations website at ir.medline.com. A replay of the webcast will be available on Medline’s Investor Relations website for 90 days following the

Medline announces participation in the Morgan Stanley 24th Annual Global Healthcare Conference

Thu, 03 Sep 2026 08:30:00 -0400

BTIG Reiterates Buy Rating on Medline Inc (MDLN)

Thu, 27 Aug 2026 05:09:24 -0400

BTIG analyst David Larsen reiterated a Buy rating and $55.00 price target on Medline Inc (NASDAQ: MDLN).

The analyst comments "On Wednesday 8/26/26, we co-hosted a Bus Tour in Illinois with members of management at Medline (MDLN, Buy, $55 PT) and a group of investors where we toured MDLN’s flagship Grayslake, IL distribution center, one of the ~45 distribution centers MDLN has in the U.S. The 1.5M square foot facility we toured was impressive and is one of the largest medical-grade distribution centers in the U.S. During our tour we had a Q&A discussion with the facility manager and we met

Form 4 Medline Inc. For: Aug 19 Filed by: Miller Stephen L

Fri, 21 Aug 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20260821/26961784.html

Form 4 Medline Inc. For: Aug 19 Filed by: Miller Stephen L

Fri, 21 Aug 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20260821/26961784.html

Form 4 Medline Inc. For: Aug 19 Filed by: Boyle James M

Fri, 21 Aug 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20260821/26961780.html

Form 4 Medline Inc. For: Aug 19 Filed by: Boyle James M

Fri, 21 Aug 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20260821/26961780.html

Form 4 Medline Inc. For: Aug 13 Filed by: GIC Special Investments Pte Ltd

Mon, 17 Aug 2026 16:15:00 -0400

si-local-file:///var/storage/secattach/20260817/26938117.html